COMPANY

Founded in 2014, PAIA Biotech has developed a growing portfolio of high throughput assays for its patented detection technology using special microplates in small volumes.

Several product lines have been launched for the platform, most recently developability assays for antibody discovery. We appreciate the support of our large network of customers and partners in developing these exciting novel assay solutions.

In addition to off-the-shelf assay products PAIA Biotech GmbH offers the first glycan screening assay service that can cope with the sample numbers and turnaround requirements of cell culture labs.  

PAIA Biotech GmbH is based in the center of Europe, in Cologne/Germany.